PRASUGREL

Course overview

PRASUGREL IS A MEDICATION USED IN THE MANAGEMENT AND TREATMENT OF ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS INTERVENTION. PRASUGREL IS A THIENOPYRIDINE, WHICH IS AN IRREVERSIBLE ANTAGONIST OF THE ADP P2Y12 RECEPTOR. THE ANTIPLATELET EFFECT OF PRASUGREL LASTS UNTIL THE LIFESPAN OF PLATELETS. PRASUGREL IS A PRODRUG THAT IS CONVERTED TO AN ACTIVE AND INACTIVE METABOLITE BY THE HEPATIC CYP SYSTEM. THIS ACTIVITY COVERS THE INDICATIONS, DOSING, CONTRAINDICATIONS, MECHANISM OF ACTION, AND MANAGEMENT OF PRASUGREL IN CASES WHERE IT CAN PROVIDE THERAPEUTIC BENEFIT.